Bae, Eun-Young
Hong, Jihyung
Bae, SeungJin
Hahn, Seokyung
An, Hyonggin
Hwang, Eun-joo
Lee, Seung-min
Lee, Tae-jin http://orcid.org/0000-0003-2539-3579
Funding for this research was provided by:
Health Insurance Review and Assessment Service
Article History
Accepted: 15 February 2022
First Online: 11 March 2022
Declarations
:
: This study was supported by Health Insurance Review and Assessment Service.
: None of the authors have any conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the revision process of the third pharmacoeconomic guidelines. The first draft of the manuscript was written by E-YB and T-JL. JH, SJB, SH, HA, E-JH, and S-ML reviewed and provided critical comments on the manuscript. E-YB revised the manuscript critically. All authors read and approved the final manuscript.